These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3998564)

  • 1. Leprosy control in Shandong Province, China, 1955-1983; some epidemiological features.
    Li HY; Pan YL; Wang Y
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):79-85. PubMed ID: 3998564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid survey on case detection of leprosy in a low endemic situation, Zhucheng County, Shandong Province, The People's Republic of China.
    Chen S; Zheng Y; Zheng M; Wang D
    Lepr Rev; 2007 Mar; 78(1):65-9. PubMed ID: 17518098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of leprosy villages and leprosaria in Shandong Province, People's Republic of China: past, present and future.
    Shumin C; Diangchang L; Bing L; Lin Z; Xioulu Y
    Lepr Rev; 2003 Sep; 74(3):222-8. PubMed ID: 14577467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey on knowledge and skills in the early diagnosis of leprosy in general health services at different levels in Shandong Province, The People's Republic of China.
    Chen S; Han C; Li B; Zheng R; Zhang L
    Lepr Rev; 2000 Mar; 71(1):57-61. PubMed ID: 10820988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences from a collaborative project on the prevention of disability in leprosy patients in Shandong Province, the People's Republic of China.
    Chen S; Zhang L; Wang Z; Zhou J; Liu Y; Mao C
    Lepr Rev; 2001 Sep; 72(3):330-6. PubMed ID: 11715279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term effect of leprosy control in both highly endemic prefectures, Weifang of Shandong and Wenshan of Yunnan].
    Li H; Weng X; Li T
    Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):333-7, 381-2. PubMed ID: 7553142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endemic leprosy in the People's Republic of Congo. An epidemiological and behavioral analysis].
    Louis JP; Trebucq A; Hengy C; Coddy-Zitsamele R; Eozenou P; Baya-Tsika N; Obvala D; Jannin J; Gelas H; Cottenot F
    Acta Leprol; 1990; 7(3):213-20. PubMed ID: 2099584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of disability, social and economic situations of people affected by leprosy in Shandong Province, People's Republic of China.
    Shumin C; Diangchang L; Bing L; Lin Z; Xioulu Y
    Lepr Rev; 2003 Sep; 74(3):215-21. PubMed ID: 14577466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of endemic leprosy in the People's Republic of the Congo. Risk factors and markers].
    Louis JP; Trebucq A; Hengy C; Coddy-Zitsamele R; Eozenou P; Baya-Tsika N; Obvala D; Jannin J; Gelas H; Cottenot F
    Med Trop (Mars); 1991; 51(1):65-70. PubMed ID: 2072851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S; Nair NG
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effect of leprosy control in two Prefectures of China, 1955-1993.
    Li HY; Weng XM; Li T; Zheng DY; Mao ZM; Ran SP; Liu FW
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):213-21. PubMed ID: 7602216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends of case detection and other indicators of leprosy in China during 1985-2002.
    Shen JP; Gupte MD; Jiang C; Manickam P; Yu MW; Li WZ
    Chin Med Sci J; 2005 Jun; 20(2):77-82. PubMed ID: 16075742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative assessment of social, economic and medical needs for ex-leprosy patients living in leprosy villages in Shandong Province, The People's Republic of China.
    Chen S; Chu T; Wang Q
    Lepr Rev; 2005 Dec; 76(4):335-47. PubMed ID: 16411513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of knowledge and skills in early diagnosis of leprosy and attitudes towards leprosy amongst doctors working in dermatological services, Shandong Province, People's Republic of China.
    Chen SM; Zhang L; Liu DC; Liu HX
    Lepr Rev; 2004 Dec; 75(4):348-56. PubMed ID: 15682972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological significance of indeterminate leprosy--a hospital based study.
    Raveendranathan O; Nair BK; Sarojini PA
    Indian J Lepr; 1991; 63(1):5-11. PubMed ID: 1919090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprophylaxis among contacts of non-lepromatous leprosy.
    Noordeen SK; Neelan PN
    Lepr India; 1976 Oct; 48(4 Suppl):635-42. PubMed ID: 800232
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of low and conventional dosages of dapsone in the treatment of lepromatous leprosy.
    Iyer CG; Balakrishnan S; Ramu G
    Lepr India; 1977 Jul; 49(3):372-86. PubMed ID: 592740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.